Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01790607 · ClinicalTrials.gov registry record · Phase 1
An Open-label, Single-dose, Intravenous Administration Study of ONO-2745/CNS 7056 in Subjects With Chronic Hepatic Impairment
A Phase 1 study, sponsored by Ono Pharma USA.
- Completed
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
NCT01790607 is a Phase 1 study that has completed, run by Ono Pharma USA. The registered enrollment target is 20 participants.
The verdict
NCT01790607, a Phase 1 study, has completed, sponsored by Ono Pharma USA.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
Study Summary
To evaluate and compare the pharmacokinetics and safety of ONO-2745/CNS 7056 in subjects with the hepatic impairment and matched healthy subjects.
Interventions
- DRUG ONO-2745 /CNS 7056
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2013-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01790607
The ClinicalTrials.gov registry entry for NCT01790607 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ono Pharma USA, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ONO-2745 /CNS 7056 is the first listed.
NCT01790607 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01790607 about?
NCT01790607 is a clinical study titled "An Open-label, Single-dose, Intravenous Administration Study of ONO-2745/CNS 7056 in Subjects With Chronic Hepatic Impairment". To evaluate and compare the pharmacokinetics and safety of ONO-2745/CNS 7056 in subjects with the hepatic impairment and matched healthy subjects.
What is the current status of trial NCT01790607?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2013-02.
What interventions are being tested in trial NCT01790607?
The interventions under investigation include: ONO-2745 /CNS 7056 (DRUG).
Who is sponsoring clinical trial NCT01790607?
This trial is sponsored by Ono Pharma USA, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.